triumph 1 retatrutide Alexandra Sowa, MD | 🚨TRIUMPH-1 data is here‼️ ~28% weight loss. Nearly half lost ≥30% We are entering an entirely new era of obesity medicine 💉🩺 TRIUMPH-1 Topline Results for Retatrutide

This month pharmacies will no longer be allowed to sell lower-cost compounded versions of the anti-obesity drug tirzepatide and costs to consumers will triple, from $350 a month to $1,000.

Curbs Late-Night Hunger

In the presence of a -aminobutyric acid type A receptor antagonist, bath application of GLP-1 (100 nM) enhanced PF-PC synaptic transmission, with an increased amplitude of evoked excitatory postsynaptic synaptic currents (EPSCs) and a decreased paired-pulse ratio

Background/Purpose: Knee osteoarthritis (KOA) is a leading cause of disability and the most common rheumatological condition worldwide

Despite these promising findings, further research is necessary to establish their long-term efficacy, optimal dosing strategies, and potential synergistic interactions of GLP-1RAs with existing pain management therapies

The papers reviewed revealed that GLP-1 analogues may have beneficial effects on additional weight loss and T2D remission postoperatively